Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma (aRCC) × envafolimab × Genitourinary × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Renal Cell Carcinoma (aRCC) 1

Interventions

pembrolizumab 1 envafolimab 1 Nivolumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07159191 2025-09-08

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Advanced Renal Cell Carcinoma (aRCC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡